港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

藥捷安康-B

193.400

+1.4000.73%

成交量：51.20萬

成交額：1.04億

市值：767.80億

市盈率：-246.42

高：210.000

開：198.800

低：192.500

收：192.000

52周最高：679.500

52周最低：20.200

股本：3.97億

香港流通股本：3.02億

量比：4.22

換手率：0.17%

股息：- -

股息率：- -

每股收益(LYR):-0.785

淨資產收益率：-39.08%

總資產收益率：-21.10%

市淨率：120.91

市盈率(LYR):-246.42

市銷率: - -

資料載入中...

總覽公司新聞公告

今年「最瘋狂」的創新藥股票下午跳水了……

第一财经广播

BiyaPay分析師：藥捷安康3個月50倍，港股版「Meme幣」橫空出世

一文刺破藥捷安康的泡沫

啱啱！崩盤了

中国基金报

藥捷安康跳水大跌超50%，振幅高達114%，其公告稱概不知悉導致股份出現股價及成交量異常變動的任何原因

老虎资讯综合

驚天暴漲神話破滅？3個月50倍「妖王」急速墜落，半日狂瀉千億！

藥捷安康跌超20%，上午一度漲近60%，振幅達86%

老虎资讯综合

藥捷安康，撐不起760億估值

藥捷安康成「妖股」：無營收，半年虧損過1億，市值2460億港元

藥捷安康-B(02617)股價及成交量異常變動不知悉導致有關波動的任何原因

創新藥的荒誕故事：營收為零的藥捷安康，市值漲超2000億

腾讯新闻潜望

這家江蘇藥企市值破2千億，僅僅幾天

生物科技馆

港股18A市值「二哥」意外換了……

2025港股醫藥最強「鬼故事」：兩天漲4倍，市值超康方、信達

市值2天暴增1200億港元，藥捷安康緣何成資本炒作新寵？

环球老虎财经

這隻沒有收入的醫藥股，上市兩個多月股價暴漲近31倍

三個交易日，市值增長超千億，未盈利的藥捷安康為何能掀起「資本狂歡」？

北水動向 | 北水淨流入港股144.73億元，狂買阿里52.85億元，沽小米、泡泡瑪特

港股收評：三大指數齊漲，恆科指再創階段新高！鋰電池股強勢，生物醫藥股尾盤拉昇

港股異動 | 藥捷安康-B(02617.HK)漲超50%破頂不到三個月股價飆漲21倍總市值突破1100億港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02617/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"藥捷安康-B","latestPrice":193.4,"timestamp":1761183251140,"preClose":192,"halted":0,"volume":512001,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7848470656843544,"marketStatus":"交易中","change":1.4,"latestTime":"10-23 09:34:11","open":198.8,"high":210,"low":192.5,"amount":103635192,"amplitude":0.091146,"askPrice":194,"askSize":3000,"bidPrice":193.4,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.6770826891106343,"tradingStatus":2,"nextMarketStatus":{"tag":"午間休市","tradingStatus":4,"beginTime":1761192000000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":192,"openAndCloseTimeList":[[1761183000000,1761192000000],[1761195600000,1761206400000]],"volumeRatio":4.217847,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.784847,"volumeRatio":4.217847,"shares":397000000,"dividePrice":0,"high":210,"amplitude":0.091146,"preClose":192,"low":192.5,"week52Low":20.2,"pbRate":"120.91","week52High":679.5,"institutionHeld":0,"latestPrice":193.4,"committee":-0.714286,"eps":-0.7848470656843544,"divideRate":0,"volume":512001,"delay":0,"ttmEps":-0.6770826891106343,"open":198.8,"prevYearClose":13.15,"prevWeekClose":203,"prevMonthClose":141.2,"prevQuarterClose":141.2,"fiveDayClose":166.1,"twentyDayClose":165.1,"sixtyDayClose":40.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-10-21","current":-283.640591,"percent":0.035714,"low":-380.446233,"twenty":-184.903189,"median":-58.041658,"eighty":-41.987471,"high":-17.403134,"avg":-102.901877,"sd":82.505554,"marketCap":68544221219},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-21","current":-264.885138,"twenty":-184.903189,"median":-58.041658,"eighty":-41.987471,"marketCap":68544221219}],"updateTime":1761148423997},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2567510170","title":"今年「最瘋狂」的創新藥股票下午跳水了……","url":"https://stock-news.laohu8.com/highlight/detail?id=2567510170","media":"第一财经广播","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567510170?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 18:02","pubTimestamp":1758016948,"startTime":"0","endTime":"0","summary":"今天，疯狂还在继续，药捷安康—B冲高679.5港元，盘中涨幅一度超过70%，市值逼近2500亿港元。药捷安康—B是一家以临床需求为导向、处于注册临床阶段的生物制药公司，专注于发现及开发肿瘤、炎症及心脏代谢疾病小分子创新疗法。连续暴涨后，9月8日港股通标的名单调整正式生效，药捷安康—B被纳入被新纳入港股通标的和创新药ETF的成份股。这意味着，ETF资金将主动及被动买入，这进一步推动了股价的上涨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161820589795d5ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161820589795d5ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06978","02617","BK1161"],"gpt_icon":0},{"id":"2567105269","title":"BiyaPay分析師：藥捷安康3個月50倍，港股版「Meme幣」橫空出世","url":"https://stock-news.laohu8.com/highlight/detail?id=2567105269","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567105269?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 18:00","pubTimestamp":1758016800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/312472","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["HSTECH","BK4614","HSCEI","02617","YANG","BK1161","07226"],"gpt_icon":0},{"id":"2567101779","title":"一文刺破藥捷安康的泡沫","url":"https://stock-news.laohu8.com/highlight/detail?id=2567101779","media":"药闻社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567101779?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 17:12","pubTimestamp":1758013970,"startTime":"0","endTime":"0","summary":"昨天在创新药普遍大跌的情况下，药捷安康却逆势大涨，市值达到了431亿元人民币。药捷安康的首发适应症胆管癌，用于三线及以后治疗，并不是很大的适应症，况且它的首发适应症是FGFR突变的后线治疗的胆管癌患者，关于这个我在此前写药捷安康的文章中已经写过了，出现FGFR突变的患者仅占胆管癌患者总数的25.2%，而它治疗的还是FGFR突变耐药后的胆管癌患者，成功率需要打折价不说，就这个市场，又是突变又是后线，算下来还有多少市场？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091617381195313551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091617381195313551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2567177413","title":"啱啱！崩盤了","url":"https://stock-news.laohu8.com/highlight/detail?id=2567177413","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567177413?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 16:07","pubTimestamp":1758010038,"startTime":"0","endTime":"0","summary":"【导读】港股惊魂大家好，今天的市场，走得比较震荡，上午跳水，午后逐渐回升，一起看看发生了什么事情。药捷安康突然闪崩9月16日，近期港股最“妖”的个股——药捷安康-B，盘中突发闪崩，早盘一度暴涨约50%，午后跳水暴跌超50%。股价从最高679.5港元跌落至不到200港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509163514897567.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509163514897567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","MTK","BK1161"],"gpt_icon":1},{"id":"1115986812","title":"藥捷安康跳水大跌超50%，振幅高達114%，其公告稱概不知悉導致股份出現股價及成交量異常變動的任何原因","url":"https://stock-news.laohu8.com/highlight/detail?id=1115986812","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115986812?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 15:27","pubTimestamp":1758007674,"startTime":"0","endTime":"0","summary":"9月16日（周二），港股药捷安康跳水大跌超50%，振幅高达114%，成交额达37亿港元，药捷安康发布公告称，概不知悉导致股份出现股价及成交量异常变动的任何原因。消息方面：$药捷安康-B(02617)$公告，公司交易价格及成交量近期出现异常变动。董事会确认，概不知悉导致股份出现该等股价及成交量异常变动之任何原因；或任何须予公布以避免股份出现虚假市场之资料；或根据上市规则须予披露之任何内幕消息。董事会亦确认，本集团之业务营运维持正常，且本集团之业务营运及财务状况并无重大变动。本公司股东及潜在投资者于买卖本公司证券时务请审慎行事。","market":"hk","thumbnail":"https://static.tigerbbs.com/4f6ec6e99c0c8b9feb7f296b78c65a54","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/4f6ec6e99c0c8b9feb7f296b78c65a54"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fab3493a94b1a7cdb8da0dfbb8764bd","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2567417221","title":"驚天暴漲神話破滅？3個月50倍「妖王」急速墜落，半日狂瀉千億！","url":"https://stock-news.laohu8.com/highlight/detail?id=2567417221","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567417221?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 15:22","pubTimestamp":1758007344,"startTime":"0","endTime":"0","summary":"港股医药最强“鬼故事”","market":"hk","thumbnail":"https://img3.gelonghui.com/08139-9466b9c7-4ef7-4873-b62b-45f380db5b8b.jpg?guru_height=562&guru_width=1000&guru_size=63193","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/08139-9466b9c7-4ef7-4873-b62b-45f380db5b8b.jpg?guru_height=562&guru_width=1000&guru_size=63193"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2845232","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["02617","MTK","BK1161"],"gpt_icon":1},{"id":"1168216682","title":"藥捷安康跌超20%，上午一度漲近60%，振幅達86%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168216682","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168216682?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 14:53","pubTimestamp":1758005617,"startTime":"0","endTime":"0","summary":"9月16日（周二），药捷安康跌超20%，报328.6港元，上午一度涨近60%，振幅达86%，成交额达29亿港元。","market":"us","thumbnail":"https://static.tigerbbs.com/02ad453d1404f80bdd57419bc97bfad5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/02ad453d1404f80bdd57419bc97bfad5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fab3493a94b1a7cdb8da0dfbb8764bd","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2567719831","title":"藥捷安康，撐不起760億估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2567719831","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567719831?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 14:40","pubTimestamp":1758004800,"startTime":"0","endTime":"0","summary":"根据相关统计显示，自药捷安康上市以来其最高涨幅超过了1900%，最高市值一度逼近1000亿港元。截至最新收盘，药捷安康的市值仍高达764亿港元，其上市以来涨幅超过了1460%。受该消息影响，药捷安康一周涨幅超过了205%。2024年6月，药捷安康再次冲击港交所IPO，直至本次才上市成功。从药捷安康的目前的基本面来看，我们认为，其估值已经存在严重的泡沫化，其也难以撑起760亿港元估值。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1757894646010799252","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1161","02617"],"gpt_icon":1},{"id":"1119637547","title":"藥捷安康成「妖股」：無營收，半年虧損過1億，市值2460億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119637547","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119637547?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 14:38","pubTimestamp":1758004717,"startTime":"0","endTime":"0","summary":"在经过连续数日大涨后，药捷安康今日再度大涨49%，截至今日午盘，公司市值2460亿港元。财报显示，药捷安康依然无营收。图片药捷安康2025年上半年研发开支为9843万元，管理费用为2747万元，期内亏损为1.23亿元，上年同期的期内亏损为1.6亿元。图片截至2025年6月30日，药捷安康持有的现金及现金等价物为4.49亿元，权益总额为5.82亿元。","market":"hk","thumbnail":"https://static.tigerbbs.com/c9635eb271432f5c92670ddd7726225b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c9635eb271432f5c92670ddd7726225b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fab3493a94b1a7cdb8da0dfbb8764bd","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/vcss4ZVHZIysOTmF3Pr3KA","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1623831535431","symbols":["02617"],"gpt_icon":1},{"id":"2567173670","title":"藥捷安康-B(02617)股價及成交量異常變動 不知悉導致有關波動的任何原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2567173670","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567173670?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 12:19","pubTimestamp":1757996353,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B(02617)发布公告，公司股份的交易价格及成交量近期出现异常变动。经就公司作出在有关情况下属合理的一切查询后，董事会确认，概不知悉(i)导致股份出现该等股价及成交量异常变动的任何原因;或(ii)任何须予公布以避免股份出现虚假市场的资料;或(iii)根据上市规则第13.09(2)条及证券及期货条例(香港法例第571章)第XIVA部须予披露的任何内幕消息。董事会亦确认，集团的业务营运维持正常，且集团的业务营运及财务状况并无重大变动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5144c09c2993e0c7de4c76f1c2196293","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2567735901","title":"創新藥的荒誕故事：營收為零的藥捷安康，市值漲超2000億","url":"https://stock-news.laohu8.com/highlight/detail?id=2567735901","media":"腾讯新闻潜望","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567735901?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 12:01","pubTimestamp":1757995260,"startTime":"0","endTime":"0","summary":"以自上市以来的累计涨幅来看，药捷安康-B成为当之无愧2025港股的“涨幅之王”。财务数据显示，药捷安康-B2023年营收118.1万元，2024年无营收，2025年上半年营收98.6万元，依旧无主营业务收入，98.6万元主要来自银行存款利息、理财收入以及政府补助。创新药因此成为2025年港股市场中涨幅最凶猛的板块。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916120441a4c8b3b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916120441a4c8b3b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","01801","02617","06978"],"gpt_icon":1},{"id":"2567717330","title":"這家江蘇藥企市值破2千億，僅僅幾天","url":"https://stock-news.laohu8.com/highlight/detail?id=2567717330","media":"生物科技馆","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567717330?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 11:52","pubTimestamp":1757994720,"startTime":"0","endTime":"0","summary":"仅仅数日，江苏一家药企在医药股市掀起惊涛骇浪——药捷安康市值一举突破 2000 亿大关，截至发稿前，其市值已飙升至 2342 亿元，成为医药股市中当之无愧的“超级明星股”，股票表现耀眼夺目。实际流通盘向来是影响股市波动的关键因素，此次药捷安康股价的暴涨，港股通买盘堪称主力推手。在港股通资金的大力涌入下，股价一路扶摇直上。这不仅体现了市场对药捷安康发展潜力的高度认可，也为其后续的发展注入了强大动力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091612062997951dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"5144c09c2993e0c7de4c76f1c2196293","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091612062997951dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2567126177","title":"港股18A市值「二哥」意外換了……","url":"https://stock-news.laohu8.com/highlight/detail?id=2567126177","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567126177?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 08:08","pubTimestamp":1757981310,"startTime":"0","endTime":"0","summary":"长期位列港股18A市值“二哥”宝座的信达生物，其市值被上市仅81天的药捷安康超越了。截至当日收盘，药捷安康股价飙升至415港元，总市值达到1647亿港元，以微弱优势超过了信达生物的1637亿港元。公告发布后的三个交易日内，公司股价累计涨幅达172.86%，市值激增约480亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091608144295301a4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091608144295301a4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617","HSCEI","HSTECH"],"gpt_icon":1},{"id":"2567804114","title":"2025港股醫藥最強「鬼故事」：兩天漲4倍，市值超康方、信達","url":"https://stock-news.laohu8.com/highlight/detail?id=2567804114","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567804114?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 20:09","pubTimestamp":1757938150,"startTime":"0","endTime":"0","summary":"2025年港股医药板块的最强“神话”出现了。如今药捷安康市值已达1647亿港元，赶超 信达生物 、 康方生物 、科伦博泰等实力选手，成为港股18A市值前五的企业。2025年半年报显示，药捷安康上半年亏损1.23亿元，较上年同期的1.6亿元有所收窄。药捷安康表示，这是世界首个且唯一已进入注册临床阶段治疗胆管癌的药物。在中国，胆管癌2024年的发病人数为10.66万人。9月8日，港股通标的名单调整正式生效，包括药捷安康在内的等20只股票被纳入其中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915202036979384bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915202036979384bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HSTECH","02617","HSCEI"],"gpt_icon":1},{"id":"2567712281","title":"市值2天暴增1200億港元，藥捷安康緣何成資本炒作新寵？","url":"https://stock-news.laohu8.com/highlight/detail?id=2567712281","media":"环球老虎财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567712281?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 20:06","pubTimestamp":1757938006,"startTime":"0","endTime":"0","summary":"3个月股价暴涨30倍，2个交易日市值暴增1200亿港元，创新药公司药捷安康横空出世，赚足了眼球。市场对这款新药颇为看好，药捷安康也因此成为了资本炒作的新宠。药捷安康成为近期港股创新药市场最靓的仔。自9月10日公告披露至9月15日，药捷安康股价大涨488.2%。截至2025年6月30日，公司的现金及现金等价物为4.49亿元。此外，药捷安康上市时，药石科技全资附属公司药石地平线资本有限公司还作为及时投资者获配82.15万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.ifeng.com/c/8mfusetZTLw","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2567911608","title":"這隻沒有收入的醫藥股，上市兩個多月股價暴漲近31倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2567911608","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567911608?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 19:29","pubTimestamp":1757935753,"startTime":"0","endTime":"0","summary":"9月15日，药捷安康股价涨幅高达115.58%，市值达到1647.13亿港元，在过去的三个交易日，即9月10日、9月11日、9月12日，公司股价涨幅已分别达到27.57%、20.78%、77.09%。药捷安康于2025年6月23日在港股市场挂牌交易，彼时公司IPO首发价只有13.15港元/股，截至9月15日，公司收盘价已高达415港元/股，股价累计涨幅约30.6倍。截至2025年6月30日，替恩戈替尼在全球已进行或正在进行共九项公司发起的临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915193220a722264b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"34164f899bcfc8d805ace59321bf0a59","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915193220a722264b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","09939","02617","BK1574"],"gpt_icon":1},{"id":"2567116827","title":"三個交易日，市值增長超千億，未盈利的藥捷安康為何能掀起「資本狂歡」？","url":"https://stock-news.laohu8.com/highlight/detail?id=2567116827","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567116827?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 18:22","pubTimestamp":1757931741,"startTime":"0","endTime":"0","summary":"据雪球网披露，自9月10日药捷安康发布积极消息以来，在短短三个交易日内，市值增长已超过1200亿港元。如此背景下，药捷安康如何缔造“十倍股”神话？一款药物获批临床，为何能掀起资本狂欢?欧洲，EMA授予其治疗胆道癌“孤儿药认定”。万事俱备，东风亦至2025年9月8日，药捷安康被正式获纳入港股通标的名单。港股新星药捷安康-B，是创新药的“真神”还是资本的狂欢？这三个人为何能摘下“诺奖风向标”？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915190357952ecdc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915190357952ecdc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":1},{"id":"1105298434","title":"北水動向 | 北水淨流入港股144.73億元，狂買阿里52.85億元，沽小米、泡泡瑪特","url":"https://stock-news.laohu8.com/highlight/detail?id=1105298434","media":"老虎資訊","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105298434?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 17:52","pubTimestamp":1757929947,"startTime":"0","endTime":"0","summary":"據統計，北水已連續17日淨買入阿里巴巴，共計468.0889億港元；連續5日淨買入中芯國際，共計17.7839億港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/3e1ae3d0f75bebef8011736e9031acae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3e1ae3d0f75bebef8011736e9031acae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"75ba2b4fb54c7864bae553cea0ea0fac","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09988","06681","01810","03690","02617","00981","01347","02800","09992","02609"],"gpt_icon":0},{"id":"2567191041","title":"港股收評：三大指數齊漲，恆科指再創階段新高！鋰電池股強勢，生物醫藥股尾盤拉昇","url":"https://stock-news.laohu8.com/highlight/detail?id=2567191041","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567191041?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 16:21","pubTimestamp":1757924496,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ad17dee5dff4a64156b96ae9f227bb9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["603127","03690","002466","HSImain","HXXD.SI","NTES","MPNGY","02833","08496","TCEHY","06127","TCHmain","HSI","09999","300750","00700","01772","TTTN","KSTmain","002460","159837","02617","MHImain","MCHmain","00951","159796","JKS","01810","03750","MIUmain","02269","HSTECH","JD","BIDU","09618","03086","HHImain","XIACY","METmain","YANG","159271","161032","BABA","09696","07226","01024","02197","ALBmain","HSCEI"],"gpt_icon":0},{"id":"2567719347","title":"港股異動 | 藥捷安康-B(02617.HK)漲超50%破頂 不到三個月股價飆漲21倍 總市值突破1100億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567719347","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567719347?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 13:51","pubTimestamp":1757915492,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":4,"totalSize":180,"code":"91000000","status":"200"}]}}